Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit

Sundar R.; Custodio A.; Petruckevich A.; Chenard-Poirier M.; Ameratunga M.; Collins D.; Lim J.; Kaye S. B.; Tunariu N.; Banerji U.; de Bono J.; Lopez J.

首页> 外文期刊>Clinical oncology >Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit

【24h】

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit

机译：专用阶段I单位晚期胆道癌患者的临床结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: Advanced biliary tract carcinomas (ABC) are malignancies with limited effective therapies for advanced disease. There is little published evidence of outcomes of ABC patients participating in phase I clinical trials.

机译：目的：晚期胆道癌（ABC）是具有有限有限的晚期疾病治疗的恶性肿瘤。只有公布的ABC患者参与I期临床试验的患者的结果。

著录项

来源
《Clinical oncology》 |2018年第3期|共7页
作者
Sundar R.; Custodio A.; Petruckevich A.; Chenard-Poirier M.; Ameratunga M.; Collins D.; Lim J.; Kaye S. B.; Tunariu N.; Banerji U.; de Bono J.; Lopez J.;
展开▼
作者单位

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

Royal Marsden Hosp Downs Rd London SM2 5PT England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Biliary tract cancer; developmental therapeutics; drug development; phase I clinical trial;

机译：胆道癌症;发育治疗;药物发展;I期临床试验;

相似文献

外文文献
中文文献
专利

1. Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit [J] . Sundar R., Custodio A., Petruckevich A., Clinical oncology . 2018,第3期

机译：专用阶段I单位晚期胆道癌患者的临床结果
2. Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit [J] . Sundar R., Custodio A., Petruckevich A., Clinical oncology . 2018,第3期

机译：专用阶段I单位晚期胆道癌患者的临床结果
3. Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. [J] . Koeberle D, Saletti P, Borner M, Journal of Clinical Oncology . 2008,第22期

机译：接受吉西他滨加卡培他滨治疗的晚期胆道癌患者的患者报告结局：瑞士临床癌症研究小组的一项多中心II期试验。
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer [O] . Seung Tae Kim, Kee-Taek Jang, Jeeyun Lee, 2015

机译：吉西他滨和奥沙利铂联合或不联合厄洛替尼治疗晚期胆道癌的3期临床结果的分子亚组分析
7. Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer [O] . 2015

机译：吉西他滨和奥沙利铂联合或不联合厄洛替尼用于晚期胆道癌的III期研究在6周时肿瘤缩小预示了良好的临床结果

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit

摘要

著录项

相似文献

相关主题

期刊订阅